HNB
TAK icon

Huntington National Bank’s Takeda Pharmaceutical TAK Stock Holding History

Huntington National Bank’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68K Buy
167
+166
+16,600% +$2.75K ﹤0.01% 2394
2026
Q1 		$19 Sell
1
-190
-99% -$3.33K ﹤0.01% 3503
2025
Q4 		$2.98K Buy
191
+190
+19,000% +$2.72K ﹤0.01% 2112
2025
Q3 		$15 Hold
1
– – ﹤0.01% 3569
2025
Q2 		$15 Hold
1
– – ﹤0.01% 3578
2025
Q1 		$15 Sell
1
-50
-98% -$701 ﹤0.01% 3603
2024
Q4 		$675 Buy
51
+50
+5,000% +$687 ﹤0.01% 2454
2024
Q3 		$14 Sell
1
-3,235
-100% -$45.9K ﹤0.01% 3622
2024
Q2 		$41.9K Buy
3,236
+718
+29% +$9.51K ﹤0.01% 1186
2024
Q1 		$35K Hold
2,518
– – ﹤0.01% 1260
2023
Q4 		$35.9K Sell
2,518
-388
-13% -$5.5K ﹤0.01% 1209
2023
Q3 		$45K Buy
2,906
+334
+13% +$5.17K ﹤0.01% 1079
2023
Q2 		$40.4K Buy
2,572
+54
+2% +$885 ﹤0.01% 1129
2023
Q1 		$41.5K Sell
2,518
-1,341
-35% -$21.4K ﹤0.01% 1074
2022
Q4 		$60.2K Buy
3,859
+1,023
+36% +$14.3K ﹤0.01% 929
2022
Q3 		$37K Hold
2,836
– – ﹤0.01% 1084
2022
Q2 		$40K Sell
2,836
-1,290
-31% -$18.4K ﹤0.01% 1075
2022
Q1 		$59K Buy
4,126
+1,290
+45% +$18.9K ﹤0.01% 1008
2021
Q4 		$39K Buy
2,836
+1
+0% +$14 ﹤0.01% 1151
2021
Q3 		$46K Sell
2,835
-441
-13% -$7.4K ﹤0.01% 1003
2021
Q2 		$55K Buy
3,276
+759
+30% +$12.9K ﹤0.01% 924
2021
Q1 		$46K Hold
2,517
– – ﹤0.01% 884
2020
Q4 		$46K Hold
2,517
– – ﹤0.01% 843
2020
Q3 		$45K Hold
2,517
– – ﹤0.01% 822
2020
Q2 		$45K Sell
2,517
-3,255
-56% -$58.4K ﹤0.01% 823
2020
Q1 		$88K Sell
5,772
-655
-10% -$11.9K ﹤0.01% 623
2019
Q4 		$126K Buy
6,427
+2,603
+68% +$49.8K ﹤0.01% 642
2019
Q3 		$65K Sell
3,824
-2,483
-39% -$42.9K ﹤0.01% 761
2019
Q2 		$112K Sell
6,307
-280
-4% -$5.09K ﹤0.01% 636
2019
Q1 		$134K Buy
+6,587
New +$133K ﹤0.01% 608

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Huntington National Bank's TAK Position: Q2 2026 in Review

Huntington National Bank increased its Takeda Pharmaceutical (TAK) stake by 16,600% in Q2 2026, buying an estimated $2.75K and bringing the position to 167 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

Huntington National Bank first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $134K in Q1 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Huntington National Bank held 167 shares of Takeda Pharmaceutical worth $2.68K as of Q2 2026.
  • Huntington National Bank bought 166 Takeda Pharmaceutical shares in Q2 2026, an estimated $2.75K.
  • Takeda Pharmaceutical made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2394 holding.
  • Huntington National Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
  • Huntington National Bank's Takeda Pharmaceutical position peaked at $134K in Q1 2019.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.